Regulators protecting patients in the news In a January warning letter to an Arizona facility that produces kids' bubblegum toothpaste, the FDA cited significant CGMP violations, including inadequate controls to prevent cross-contamination from potent ingredients, insufficient cleaning validation, release of drug products without proper laboratory testing, and a lack of effective quality unit oversight
The main adverse events reported by male AAS users to SERMs (clomiphene and tamoxifen) were decreased libido and erectile dysfunction (24%), acne (21%), fatigue (19%), mood disorders (13%), visual disturbances (5%), arthralgia (4%), insomnia (4%), and hot flushes (2%)
There are a few options on the market, such as Rybelsus and Wegovy
Mar 10 2021;31(3):699-704